July 1 (Reuters) - The U.S. Federal Trade Commission has
opened an investigation into Teva Pharmaceuticals over
the company's refusal to take down about two dozen patents for
its asthma and COPD inhalers, the Washington Post reported on
Monday citing agency documents.
(Reporting by Gursimran Kaur in Bengaluru; Editing by Saumyadeb
Chakrabarty)